Form 8-K - Current report:
SEC Accession No. 0001104659-25-074503
Filing Date
2025-08-06
Accepted
2025-08-06 06:51:26
Documents
14
Period of Report
2025-07-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2522677d1_8k.htm   iXBRL 8-K 35170
2 EXHIBIT 10.1 tm2522677d1_ex10-1.htm EX-10.1 208267
3 EXHIBIT 10.2 tm2522677d1_ex10-2.htm EX-10.2 80439
  Complete submission text file 0001104659-25-074503.txt   556466

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mnk-20250731.xsd EX-101.SCH 3023
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20250731_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20250731_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2522677d1_8k_htm.xml XML 3557
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 251187359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)